Literature DB >> 8793857

Functional analysis of the human androgen receptor promoter.

K K Takane1, M J McPhaul.   

Abstract

Although androgen receptor levels vary widely during development, our previous studies have suggested that a single promoter is active in a number of human and rat tissues and cell lines. To examine the elements controlling androgen receptor expression, we performed deletion mapping and site-directed mutagenesis of the human androgen receptor promoter and assayed these promoter fusions in human cell lines that produce the androgen receptor as well as those deficient in the androgen receptor, both in the presence and absence of androgen. Our studies identify a region (-74 to +87) surrounding the site of transcription initiation that constitutes the core of the androgen receptor promoter. When assayed in T47D cells (an AR-expressing cell line), this segment was sufficient to direct the expression of reporter genes at levels similar to that observed for larger promoter fragments, and further deletions led to an appreciable loss of promoter activity. DNA sequences surrounding this region appear to modulate the activity of this minimal promoter in a cooperative fashion. Site-directed mutagenesis and mobility shift assays demonstrated the importance of regulatory regions upstream of the transcription initiation site including an SP1 binding site and two segments with similarities to consensus HLH protein binding sites (E-boxes). Androgen treatment did not cause a decrease in activity of any of the transiently transfected promoter fusions tested, suggesting that the promoter does not contain the information necessary for autoregulation or that a posttranscriptional or posttranslational mechanism is responsible for the regulation of AR mRNA by ligand. Furthermore, the androgen receptor promoter fusions displayed differing transcriptional activities when transfected into two cell lines deficient in androgen receptor expression suggesting heterogeneity in the mechanisms responsible for this deficiency.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8793857     DOI: 10.1016/0303-7207(96)03800-2

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  14 in total

1.  Identification of Sp1-elements in the promoter region of human homeobox gene NKX3.1.

Authors:  Chun-Xiao Yu; Tong Jin; Wei-Wen Chen; Peng-Ju Zhang; Wen-Wen Liu; Heng-Yun Guan; Ju Zhang; Qing-Wei Liu; An-Li Jiang
Journal:  Mol Biol Rep       Date:  2009-03-05       Impact factor: 2.316

Review 2.  The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health.

Authors:  Marià Alemany
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

3.  LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion.

Authors:  Yirong Li; Longgui Wang; Miao Zhang; Jonathan Melamed; Xiaomei Liu; Robert Reiter; Jianjun Wei; Yi Peng; Xuanyi Zou; Angel Pellicer; Michael J Garabedian; Anna Ferrari; Peng Lee
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

4.  Androgen receptor survival signaling is blocked by anti-beta2-microglobulin monoclonal antibody via a MAPK/lipogenic pathway in human prostate cancer cells.

Authors:  Wen-Chin Huang; Haiyen E Zhau; Leland W K Chung
Journal:  J Biol Chem       Date:  2010-01-13       Impact factor: 5.157

5.  Kava components down-regulate expression of AR and AR splice variants and reduce growth in patient-derived prostate cancer xenografts in mice.

Authors:  Xuesen Li; Zhongbo Liu; Xia Xu; Christopher A Blair; Zheng Sun; Jun Xie; Michael B Lilly; Xiaolin Zi
Journal:  PLoS One       Date:  2012-02-09       Impact factor: 3.240

6.  Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events.

Authors:  Kate M Peters; Stacey L Edwards; Shalima S Nair; Juliet D French; Peter J Bailey; Kathryn Salkield; Sandra Stein; Sarah Wagner; Glenn D Francis; Susan J Clark; Melissa A Brown
Journal:  BMC Cancer       Date:  2012-04-02       Impact factor: 4.430

Review 7.  Androgen and estrogen sensitivity of bird song: a comparative view on gene regulatory levels.

Authors:  Carolina Frankl-Vilches; Manfred Gahr
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2017-12-06       Impact factor: 1.836

8.  Mithramycin targets sp1 and the androgen receptor transcription level-potential therapeutic role in advanced prostate cancer.

Authors:  Long G Wang; Anna C Ferrari
Journal:  Transl Oncogenomics       Date:  2006-10-11

9.  An Sp1 Modulated Regulatory Region Unique to Higher Primates Regulates Human Androgen Receptor Promoter Activity in Prostate Cancer Cells.

Authors:  Colin W Hay; Irene Hunter; Alasdair MacKenzie; Iain J McEwan
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

10.  Establishment of prostate cancer spheres from a prostate cancer cell line after phenethyl isothiocyanate treatment and discovery of androgen-dependent reversible differentiation between sphere and neuroendocrine cells.

Authors:  Yamei Chen; Shundong Cang; Liying Han; Christina Liu; Patrick Yang; Zeeshan Solangi; Quanyi Lu; Delong Liu; J W Chiao
Journal:  Oncotarget       Date:  2016-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.